ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2297

Serum Urate and Its Association with Race in Young Adults: Baseline Analysis from a Randomized Clinical Trial

Michael B. Saddekni1, Angelo L. Gaffo1, Phillip J. Foster1, Elizabeth J. Rahn1, Stephanie R. Biggers1, Peng Li2 and Kenneth G. Saag1, 1Department of Medicine, Division of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: cross-sectional studies, hyperuricemia, race/ethnicity and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Increased levels of serum urate (sUA) have been reported in association with hypertension, chronic kidney disease, and obesity. All these conditions are over-represented in US African Americans, who also have greater environmental risk factors for developing hyperuricemia including elevated fructose intake.  Our group has previously reported that young African Americans have lower sUA concentrations than Caucasians after adjustment for clinical and demographic factors. Objectives: To determine whether there is a differential association between sUA and race in young adults.

Methods:  We examined baseline data on consecutively enrolled individuals (age 18 – 40 years) in an interventional study aimed at lowering blood pressure (BP) through the administration of a urate-lowering therapy. African Americans were over-represented in the sample by study design. Enrollment criteria included a sUA of ≥ 5.0 mg/dL for men or ≥ 4.0 mg/dL for women. After sUA means comparisons between African Americans and other races using t-test, we performed multivariable adjustments for age, sex, serum creatinine, and body mass index (BMI) in a multiple linear regression model.

Results: Sixty-nine participants recruited from Birmingham, AL were included in the analysis. Participants had a mean age (±standard deviation) of 29.0 ± 6.9 years, 30% were female, 43% were African Americans (AAs), and the mean BMI was 29.0 ± 6.0 kg/m². The mean sUA was 5.9 ± 1.1 mg/dL (range: 3.9 to 8.5 mg/dL). We found a significantly lower sUA for African Americans compared to persons of other races (5.5 ± 1.2 mg/dL vs 6.3 ± 1.0 mg/dL, p= 0.009).  After multivariable analysis the difference in sUA between African Americans and other races was attenuated to non-significance (p= 0.33) due to the effects of BMI and sex.  As expected, the association between sUA and sex was significant (Table).

Conclusion:   In this cross-sectional analysis of young adults, African Americans had lower sUA concentrations than other races. However, in our model this difference is explained by the effect of sex differences in sUA and BMI. A potential limitation is that participants were enrolled after they met a sUA threshold so not all the ranges of sUA in a normal population are represented in this analysis.  Larger studies will be needed to fully address this question.  Table. Multivariable regression model on the association between serum urate and race among young adults (n=69)

Variable

Estimate

(95% confidence interval)

p

Race (African-Americans versus other races)     

-0.32 (-0.88 – 0.24)

0.3

Age (per year)

0.009 (-0.03 – 0.04)

0.6

Sex (men versus women)

1.44 (0.75 – 2.14)

<0.001

BMI (per unit of kg/m2)

0.04 (0.01-0.08)

0.02

Serum creatinine (per milligram per deciliter)

0.42 (-1.17  – 2.03)

0.6

BMI= Body-mass index  


Disclosure: M. B. Saddekni, None; A. L. Gaffo, US Government, 3,Cymabay, 5,Ardea, 5,Amgen, 2,AstraZeneca, 2; P. J. Foster, None; E. J. Rahn, None; S. R. Biggers, None; P. Li, None; K. G. Saag, Ardea/AstraZeneca, 5,Crealta, 5,Takeda, 5,Ardea/AstraZeneca, 2,Crealta, 2,Takeda, 2.

To cite this abstract in AMA style:

Saddekni MB, Gaffo AL, Foster PJ, Rahn EJ, Biggers SR, Li P, Saag KG. Serum Urate and Its Association with Race in Young Adults: Baseline Analysis from a Randomized Clinical Trial [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/serum-urate-and-its-association-with-race-in-young-adults-baseline-analysis-from-a-randomized-clinical-trial/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/serum-urate-and-its-association-with-race-in-young-adults-baseline-analysis-from-a-randomized-clinical-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology